Kolkata, India – A stem cell banking company has announced that it will be working with Duke Medicine to help provide autism treatment options for patients in India.
Cordlife India will endeavor to assist those on the spectrum by allowing them to participate in a research development program through the university. The initiative has been made following Duke’s medical program being awarded $15 million to conduct research. The study would therefore allow experts to ascertain the benefit of using umbilical cord blood stem cells to treat autism and other brain disorders.
Stem cells are undifferentiated biological cells that are found in multicellular organisms including mammals. Cord blood specifically, is considered to be multipotent and can aid in the treatment of various afflictions that affect humans. Although use of stem cells has become a controversial topic, many members of the medical community continue to try to fully ascertain its efficacy.
With the prevalence of autism rising throughout the globe, members of the scientific community are increasingly using cell therapy as a focal point for research in hopes of discovering an effective treatment for the baffling disorder.
Jeremy Yee, CEO of Cordlife states:
” (It) confirms our long held beliefs that potential for future use of cord blood and cord lining will grow with the advancement in cell therapy.”
The original article by on The Hindi Business Line website can be read here
Contributed by Althea Estrella Violeta